Home Important Safety Instructions Prescribing Information Medication Guide Instructions for Use Health Care Professionals Rheumatology Professionals About Exemptia What is Exemptia? How Exemptia works? Mechanism of Action Dosing & Administration Efficacy & Safety Efficacy Safety Exemptia – Clinical Data Phase III clinical data Support Information from Zydus About Zydus Zydus Innovation programme Adalimumab Adalimumab Biosimilar Adverse Event Reporting Conditions Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis Juvenile Idiopathic Arthritis Crohn’s Disease & Ulcerative Colitis Important Links Healthcare Professional Site ExemptiaTM Care – Patient Support Programme Important Safety Instructions Downloads
